{
    "organizations": [],
    "uuid": "bcedbf9e70d1860baeaa31f5684033b0272807ed",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-corvidia-therapeutics-secures-60-m/brief-corvidia-therapeutics-secures-60-mln-in-series-b-funding-to-accelerate-clinical-work-idUSASC09X96",
    "ord_in_thread": 0,
    "title": "BRIEF-Corvidia Therapeutics Secures $60 Mln In Series B Funding To Accelerate Clinical Work",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 25 (Reuters) -\n* CORVIDIA THERAPEUTICS SECURES $60 MILLION IN SERIES B FUNDING TO ACCELERATE CLINICAL WORK\n* CORVIDIA THERAPEUTICS INC, A CLINICAL STAGE BIOTECHNOLOGY COMPANY, SAYS VENROCK LED THE $60 MILLION SERIES B FINANCING Source text for Eikon:\n ",
    "published": "2018-04-25T19:18:00.000+03:00",
    "crawled": "2018-04-26T20:44:27.010+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "corvidia",
        "therapeutic",
        "secures",
        "million",
        "series",
        "b",
        "funding",
        "accelerate",
        "clinical",
        "work",
        "corvidia",
        "therapeutic",
        "inc",
        "clinical",
        "stage",
        "biotechnology",
        "company",
        "say",
        "venrock",
        "led",
        "million",
        "series",
        "b",
        "financing",
        "source",
        "text",
        "eikon"
    ]
}